â??A Clinical Study to Evaluate the Efficacy of Ayurvedic formulations NIA/DG/2015/01 and NIA/DG/2020/01 along with Walking in the Management of Newly Diagnosed Primary Hypertension.â??

â??A Double-Blind Randomized Clinical Trial to Evaluate the Efficacy of Ayurvedic Formulations NIA/DG/2015/01 and NIA/DG/2020/01 along with Chankramana (Walking) in the Management of Newly Diagnosed Primary Hypertension.â??

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/11/046970

Enrollment

200

Registered

2022-11-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients belonging to both sexes between the age group 18 to 60 years without major comorbidities. 2. Patients who already diagnosed as primary hypertension & not taking any antihypertensive medication will be selected. 3. Duration of disease- 1-3 month. (Patients whose primary hypertension has been diagnosed before 3 months from the date of screening for this trial will be considered as newly diagnosed cases of primary hypertension.) 4. Mild to moderate grade patients of hypertension as per 8th JNC. 5. Patients having systolic blood pressure >=140 upto 180 mm of hg and diastolic blood pressure >= 90 upto 110 mm of hg will be selected for the study. 6. Patients who are willing to fill the informed consent form. 7. Patients who are willing to download suitable mobile applications to record their walking program.

Exclusion criteria

Exclusion criteria: 1. Known cases of Secondary hypertension, renal diseases, Diabetic Mellitus. 2. Known cases of Pregnancy induced hypertension. 3. Known cases of Ventricular hypertrophy, coarctation of aorta, Portal hypertension, and renal artery stenosis induced hypertension. 4. Patients using other antihypertensive medicines of conventional biomedicine / AYUSH systems / any other system. 5. Patients using drugs like Oral Contraceptive Pills, steroids. 6. Patient with no evidence of any target organ damage.

Design outcomes

Primary

Measure	Time frame
Reduction the high systolic and diastolic blood pressure to normal range.Timepoint: Blood pressure will be recorded at 15th days,30,45,60,75,90 day	—

Secondary

Measure	Time frame
Improvement in the subjective parameters of primary hypertension.Timepoint: at 15,30,45,60,75,90 day	—

Countries

India

Contacts

Public ContactDr Pratibha

National Institute of Ayurveda Deemed to be University Jaipur Rajasthan

sudipt@gmail.com9828876668

Outcome results